Caporusso et al case series1
In real-world patients (retrospective case series), NuShield® was used in a wide variety of wounds (N=50), including VLUs (n=14), DFUs (n=24), and other wounds (pressure ulcers, nonhealing surgical, ischemic, mixed etiology, and nonhealing amputation; n=12).1DFU=diabetic foot ulcer; VLU=venous leg ulcer
Median time to wound closure1
Percentage of wounds closed by week1
Of those wounds that did not achieve wound closure, 9 (18%) had >90% wound closure, and 8 (16%) had wound closures ranging from 60% to 90% by the last observation.1
- Caporusso J, et al. Wounds. 2019;31(4 Suppl):S19-S27.